Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 272-276

  Poursoltan, Pirooz ^a,b   Currey, Nicola ^c   Pangon, Laurent ^c   van Kralingen, Christa ^c   Selinger, Christina I ^a,c   Mahar, Annabelle ^a   Cooper, Wendy A ^a,d   Kennedy, Catherine W ^e   McCaughan, Brian C ^a   Trent, Ronald ^a,b   Kohonen Corish, Maija R J ^c,d,f  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e Strathfield Private Hospital   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

APC; DNA methylation; Loss of heterozygosity; MCC; Non small cell lung cancer

Indexed keywords

BETA ACTIN; MUTATED IN COLORECTAL CANCER PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; GENES, MCC; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84863777078     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.04.001     Document Type: Article

References (35)

1. Balsara B.R., Testa J.R. Chromosomal imbalances in human lung cancer. Oncogene 2002, 21:6877-6883.
2. Tsou J.A., Hagen J.A., Carpenter C.L., Laird-Offringa I.A. DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 2002, 21:5450-5461.
3. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004, 4:707-717.
4. Hitchins M.P., Lin V.A., Buckle A., Cheong K., Halani N., Ku S., et al. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res 2007, 67:9107-9116.
5. Stransky N., Vallot C., Reyal F., Bernard-Pierrot I., de Medina S.G., Segraves R., et al. Regional copy number-independent deregulation of transcription in cancer. Nat Genet 2006, 38:1386-1396.
6. Seng T.J., Currey N., Cooper W.A., Lee C.S., Chan C., Horvath L., et al. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma. Br J Cancer 2008, 99:375-382.
7. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
8. Fodde R., Smits R., Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001, 1:55-67.
9. Virmani A.K., Rathi A., Sathyanarayana U.G., Padar A., Huang C.X., Cunnigham H.T., et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 2001, 7:1998-2004.
10. Brabender J., Usadel H., Danenberg K.D., Metzger R., Schneider P.M., Lord R.V., et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001, 20:3528-3532.
11. Kinzler K.W., Nilbert M.C., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991, 251:1366-1370.
12. Ashton-Rickardt P.G., Wyllie A.H., Bird C.C., Dunlop M.G., Steel C.M., Morris R.G., et al. MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene 1991, 6:1881-1886.
13. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665-669.
14. Curtis L.J., Bubb V.J., Gledhill S., Morris R.G., Bird C.C., Wyllie A.H. Loss of heterozygosity of MCC is not associated with mutation of the retained allele in sporadic colorectal cancer. Hum Mol Genet 1994, 3:443-446.
15. Kohonen-Corish M.R., Sigglekow N.D., Susanto J., Chapuis P.H., Bokey E.L., Dent O.F., et al. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 2007, 26:4435-4441.
16. Jass J.R., Whitehall V.L., Young J., Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology 2002, 123:862-876.
17. Fukuyama R., Niculaita R., Ng K.P., Obusez E., Sanchez J., Kalady M., et al. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene 2008, 27:6044-6055.
18. Fong K.M., Zimmerman P.V., Smith P.J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res 1995, 55:220-223.
19. Oreffo V.I., Robinson S., You M., Wu M.C., Malkinson A.M. Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia. Mol Carcinog 1998, 21:37-49.
20. Rohrbeck A., Borlak J. Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS ONE 2009, 4:e7315.
21. Selinger C.I., Cooper W.A., Al-Sohaily S., Mladenova D.N., Pangon L., Kennedy C.W., et al. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 2011, 6:1-11.
22. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Danenberg P.V., Laird P.W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 1999, 59:2302-2306.
23. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32.
24. Spirio L., Nelson L., Ward K., Burt R., White R., Leppert M. A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 1993, 52:286-296.
25. Boynton R.F., Blount P.L., Yin J., Brown V.L., Huang Y., Tong Y., et al. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 1992, 89:3385-3388.
26. Matsumine A., Senda T., Baeg G.H., Roy B.C., Nakamura Y., Noda M., et al. MCC, a cytoplasmic protein that blocks cell cycle progression from the G0/G1 to S phase. J Biol Chem 1996, 271:10341-10346.
27. Senda T., Matsumine A., Yanai H., Akiyama T. Localization of MCC (mutated in colorectal cancer) in various tissues of mice and its involvement in cell differentiation. J Histochem Cytochem 1999, 47:1149-1158.
28. Arnaud C., Sebbagh M., Nola S., Audebert S., Bidaut G., Hermant A., et al. MCC, a new interacting protein for Scrib, is required for cell migration in epithelial cells. FEBS Lett 2009, 583:2326-2332.
29. Pangon L, van Kralingen C, Abas M, Daly RJ, Musgrove EA, Kohonen-Corish MRJ. The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells. Biochim Biophys Acta: Mol Cell Res; in press. doi:10.1016/j.bbamcr.2012.03.011.
30. Pangon L., Sigglekow N.D., Larance M., Al-Sohaily S., Mladenova D., Selinger C., et al. 'Mutated in colorectal cancer' (MCC) is a novel target of the UV-induced DNA damage response. Genes Cancer 2010, 1:917-926.
31. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004, 6:97-105.
32. Sigglekow N.D., Pangon L., Brummer T., Molloy M., Hawkins N.J., Ward R.L., et al. Mutated in colorectal cancer protein modulates the NFkB pathway. Anticancer Res 2012, 32:73-80.
33. Starr T.K., Allaei R., Silverstein K.A., Staggs R.A., Sarver A.L., Bergemann T.L., et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 2009, 323:1747-1750.
34. Huang Y., Boynton R.F., Blount P.L., Silverstein R.J., Yin J., Tong Y., et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 1992, 52:6525-6530.
35. Saito K., Kawakami K., Matsumoto I., Oda M., Watanabe G., Minamoto T. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin Cancer Res 2010, 16:2418-2426.